Exploratory P2 Trial to Evaluate Efficacy and Safety of Clotinab ® (Abciximab) in Acute MI Patients
Condition:   Acute Myocardial Infarction Interventions:   Biological: Abciximab;   Biological: Placebo Sponsor:   ISU Abxis Co., Ltd. Active, not recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2016 Category: Research Source Type: clinical trials

Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
Conditions:   Sickle Cell Disease;   Hb-SS Disease With Vasoocclusive Pain;   Hemoglobin SS Disease With Vasoocclusive Crisis;   Other Sickle Cell Disease With Vaso-Occlusive Pain;   Hemoglobin SS Disease With CrisisInterventions:   Drug: Abciximab;   Drug: Placebo;   Other: Intravenous hydration;   Drug: Ibuprofen;   Drug: Parenteral narcotic;   Other: Incentive spirometry;   Other: Supplemental oxygenSponsors:   St. Louis University;   Janssen Services, LLCWithdrawn - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2013 Category: Research Source Type: clinical trials